文献速递男科与性医学

加巴喷丁用于阴囊手术后疼痛控制及减少阿片类药物使用:一项随机对照临床试验

Gabapentin for Postoperative Pain Control and Opioid Reduction in Scrotal Surgery: A Randomized Controlled Clinical Trial.
PubMed 文献 · J Urol · 2024-02-21

这项随机双盲安慰剂对照试验纳入70例接受阴囊手术的男性不育患者,评估围手术期加巴喷丁(术前600 mg、术后300 mg每日三次共3天)的镇痛效果。结果显示加巴喷丁组初始和最终平均疼痛评分均低于安慰剂组,但阿片类药物使用、患者满意度和不良事件无显著差异。作者认为加巴喷丁可考虑作为多模式镇痛策略的一部分。

要点

  • 加巴喷丁组初始术后平均疼痛评分较安慰剂组低1.14分(95%CI -2.21至-0.08,P=0.035)。
  • 加巴喷丁组最终平均疼痛评分较安慰剂组低1.27分(95%CI -2.23至-0.32,P=0.0097)。
  • 阿片类药物使用、患者满意度和不良事件在两组间无统计学显著差异。

核心结论

  • 这些数据表明围手术期加巴喷丁可使阴囊手术后疼痛出现统计学和临床显著的降低。
  • 虽然无证据显示对阿片类药物使用或患者满意度有影响,但鉴于不良事件风险低,可考虑将其作为多模式疼痛管理策略的一部分。

研究设计与样本

  • 随机双盲安慰剂对照试验,筛查97例,纳入74例并随机分组,4例失访,最终分析70例(加巴喷丁组35例,安慰剂组35例)。
  • 研究对象为接受单外科医生阴囊手术的健康男性不育患者。
  • 干预为加巴喷丁术前2小时600 mg、术后300 mg每日三次共3天,对照为无活性安慰剂。
  • 主要结局为术后疼痛评分差异,次要结局包括阿片类药物使用、患者满意度和不良事件差异。

主要发现

  • 初始术后平均疼痛评分差异为-1.14(95%CI -2.21至-0.08,P=0.035),加巴喷丁组低于安慰剂组。
  • 最终平均疼痛评分差异为-1.27(95%CI -2.23至-0.32,P=0.0097),加巴喷丁组低于安慰剂组。
  • 阿片类药物使用、患者满意度和不良事件在两组间无统计学显著差异。

临床怎么用

  • 作者认为,鉴于不良事件风险低,可考虑将围手术期加巴喷丁作为多模式疼痛管理策略的一部分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess the safety and efficacy of gabapentin in reducing postoperative pain among patients undergoing scrotal surgery for male infertility by conducting a randomized, double-blind, placebo-controlled trial. MATERIALS AND METHODS: In this randomized, double-blind, placebo-controlled trial, healthy men undergoing scrotal surgery with a single surgeon were randomized to receive either (1) gabapentin 600 mg given 2 hours preoperatively and 300 mg taken 3 times a day postoperatively for 3 days, or (2) inactive placebo. The primary outcome measure was difference in postoperative pain scores. Secondary outcomes included differences in opioid usage, patient satisfaction, and adverse events. RESULTS: Of 97 patients screened, 74 enrolled and underwent randomization. Of these, 4 men were lost to follow-up, and 70 were included in the final analysis (35 gabapentin, 35 placebo). Both differences in initial postoperative mean pain score (-1.14, 95% CI -2.21 to -0.08, P = .035) and final mean pain score differences (-1.27, 95% CI -2.23 to -0.32, P = .0097) indicated lower gabapentin pain compared to placebo. There were no statistically significant differences in opioid usage, patient satisfaction, or adverse events. CONCLUSIONS: These data suggest that perioperative gabapentin results in a statistically and clinically significant decrease in pain following scrotal surgery. While there was no evidence of an impact on opioid usage or patient satisfaction, given the low risk of adverse events, it may be considered as part of a multimodal pain management strategy.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Punjani N, Marinaro JA, Kang C, et al. Gabapentin for Postoperative Pain Control and Opioid Reduction in Scrotal Surgery: A Randomized Controlled Clinical Trial. J Urol. 2024. PMID: 38382042. doi:10.1097/JU.0000000000003884

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。